|
|
Effects of Three Different Blood Purification Methods on Serum β2-MG Calcium and Phosphorus Concentrations and Parathyroid Hormone Levels in Patients with Uremia |
WANG Yujing |
Haikou Hospital Affiliated to Xiangya Medical College, Central South University, Hainan Haikou 570208, China |
|
|
Abstract Objective:To analyze the effects of three different blood purification methods on serum β2 microglobulin (β2-MG), calcium and phosphorus concentrations and parathyroid hormone (PTH) levels in patients with uremia. Methods:A total of 100 patients with uremia who were admitted to the hospital during the period from May 2015 to May 2018 were selected as subjects. They were randomly divided into HFHD group (treated with high-flux hemodialysis, n=34), HDF group (treated with hemodiafiltration, n=32) and HD+HP group (treated with hemodialysis and hemoperfusion, n=34). All groups were given 3 months of treatment. The total treatment response rate, serum creatinine (Scr), blood urea nitrogen (BUN), KT / V value, serum β2-MG, blood calcium, serum phosphorus, calcium-phosphorus product and PTH levels before and after treatment were compared among the three groups. Results:The total treatment response rate of HFHD group (91.18%)or HD+HP group (94.12%) were significantly higher than that of HDF group (68.75%)(P<0.05). The BUN and Scr in all groups were after treatment, but there was no significant difference in BUN, Scr or KT/V value among the three groups (P>0.05). Theserum β2-MG, serum phosphorus, calcium-phosphorus product and PTH levels in HFHD group and HD+HP group were significantly lower than those in HDF group, with statistically significant differences between HFHD group and HD+HP group (P<0.05). Conclusion: All of the three blood purification methods can well treat uremia. The therapeutic effects and the improvement of serum β2-MG, blood phosphorus, calcium-phosphorus product and PTH by HFHD or HD+HP are better than HDF, especially HD+HP.
|
|
|
|
|
[1] Brunelli SM,Claxton A,Mehta S,et al.Consequences of hemolytic uremic syndrome among hemodialysis patients[J].Nephrol,2015,28(3):361~367. [2] 孙桂芳,张宝霞,姚晓哲,等.血液灌流联合血液透析治疗尿毒症的临床价值分析[J].现代生物医学进展,2017,17(18):3553~3556. [3] 张俊,王倩,黄新忠,等.四种血液净化方式对尿毒症患者甲状旁腺激素、FGF23、钙磷及炎症因子的影响[J].南通大学学报(医学版),2017,37(4):315~318. [4] Liakopoulos V,Demirtzi P,Mikropoulos DG,et al.Intraocular pressure changes during hemodialysis[J].Int Urol Nephrol,2015,47(10):1685~1690. [5] 葛均波,徐永健.内科学[M].第8版.北京:人民卫生出版社,2014. [6] 张文阁,李强,刘翠,等.血液透析联合不同时机的血液灌流对尿毒症患者中分子毒素清除效果的探讨[J].医学研究杂志,2017,46(11):101~105. [7] Nangaku M,Mimura I,Yamaguchi J,et al.Role of uremic toxins in erythropoiesis-stimulating agent resistance in chronic kidney disease and dialysis patients[J].Ren Nutr,2015,25(2):160~163. [8] 佘伟萍,杨伟鹏,刘奕深,等.血液透析联合血液灌流治疗维持性透析患者钙磷代谢紊乱的疗效观察[J].临床与病理杂志,2016,36(10):1579~1584. [9] 陈璐.血液灌流联合血液透析治疗对尿毒症患者血清β2-MG、PTH水平及预后的影响[J].热带医学杂志,2018,18(2):225~228. [10] 王浩,童皖宁,冯冰,等.不同血液净化方式改善老年尿毒症患者皮肤瘙痒效果观察[J].人民军医杂志,2016,59(11):1156~1158. |
|
|
|